Behaviour of the Antitumor Agent Vanadocene Dichloride in Physiological and Therapeutic Media, Blood Plasma and Human Blood - An EPR Study
1997

Behavior of the Antitumor Agent Vanadocene Dichloride

publication 10 minutes Evidence: moderate

Author Information

Author(s): Jaromir Vinklarek, Ivan Pavlik, Zdenek Cernosek

Primary Institution: Department of General and Inorganic Chemistry, Faculty of Chemical Technology, University of Pardubice

Hypothesis

What are the interactions of vanadocene dichloride in physiological and therapeutic media?

Conclusion

Vanadocene dichloride does not react with blood components in its first coordination sphere, remaining stable in physiological solutions.

Supporting Evidence

  • Vanadocene dichloride was shown to have antiproliferative effects against various tumor cells.
  • EPR spectra indicated the presence of specific vanadocene species in physiological solutions.
  • The study identified that vanadocene does not interact with blood components in its first coordination sphere.
  • Hydrolysis products of vanadocene do not react with components of physiological solutions.

Takeaway

Vanadocene dichloride is a medicine that helps fight cancer, and it behaves the same way in blood as it does in water.

Methodology

EPR spectroscopy was used to study the behavior of vanadocene dichloride in various media.

Limitations

The study primarily focuses on the behavior of vanadocene in specific physiological solutions and may not cover all biological interactions.

Participant Demographics

The study involved human blood from a healthy male aged 26.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication